Thanks for at least giving an articulate response and I respect the fact that you disagree with me as well as my way of expressing my opinions. You are entitled to feel that way. All good!
I fully admit it’s not conventional to have this approach as a shareholder, but I’ve found it works very well over the longer term, and I have learnt far more and been a better investor by challenging the consensus view. Not to undermine confidence in Telix, but prodding a little in order to get some reasonable answers to my genuine concerns. Let’s face it, nothing I say here or anyone else is going to move the SP in a meaningful way. It’ll be determined by the scientific results and how we fare against the competition.
I want the SP to go to the moon as much as anyone else but judging by the responses I’m getting I have my doubts this will eventuate, but I’m still hanging in there for now. This is by far the most impartial and defensive group of investors I have ever encountered anywhere in my career. The attitude here is, if you don’t tow the line, you don’t belong here and we will shut you down. It just gives me cause for concern as an investor and is why I keep pushing and will continue to.
Anyway to get back to your original comment about the threat from competitors, being more than 2.5 years away, that is not my understanding. It could be as little as 18 months away depending on results. Or it may never happen! Still a risk in my books. And the suite of other products you refer to in my opinion, is still a very big IF after recent events with the approval process. Happy to be proven wrong as always.
- Forums
- ASX - By Stock
- TLX
- Telix ASX TLX Breaking News & Current Commentary
TLX
telix pharmaceuticals limited
Add to My Watchlist
1.73%
!
$24.73

Telix ASX TLX Breaking News & Current Commentary, page-2817
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$24.73 |
Change
0.420(1.73%) |
Mkt cap ! $8.368B |
Open | High | Low | Value | Volume |
$24.10 | $24.81 | $23.68 | $29.13M | 1.196M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 23 | $24.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$24.85 | 3 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23 | 24.700 |
1 | 3284 | 24.660 |
1 | 2000 | 24.650 |
1 | 3284 | 24.620 |
1 | 200 | 24.600 |
Price($) | Vol. | No. |
---|---|---|
24.850 | 3 | 1 |
24.870 | 3284 | 1 |
24.890 | 200 | 1 |
24.900 | 195 | 1 |
24.910 | 3284 | 1 |
Last trade - 16.12pm 26/06/2025 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online